Monoclonal antibodies against COVID-19 have high potential, but efficacy against emerging variants muddled: GlobalData Read more
Immuno-oncology to be a dominant class of drugs for hepatocellular carcinoma by 2029: GlobalData Read more
Efforts to ramp up production of COVID-19 vaccines, easy availability underway: Renu Swarup Read more
Pharma firms with approval for projects under PLI scheme should start production at the earliest: Gowda Read more